(Q46337835)

21 December 2017

title

Hepatitis B vaccination of susceptible elderly residents of long term care facilities during a hepatitis B outbreak (English)

1 reference

21 December 2017

1 reference

3

1 reference

21 December 2017

author name string

Roxanne E Williams

1

1 reference

21 December 2017

Arlene C Sena

2

1 reference

21 December 2017

Zack S Moore

4

1 reference

21 December 2017

Umid M Sharapov

5

1 reference

21 December 2017

Jan Drobenuic

6

1 reference

21 December 2017

Dale J Hu

7

1 reference

21 December 2017

Hattie W Wood

8

1 reference

21 December 2017

Jian Xing

9

1 reference

21 December 2017

Philip R Spradling

10

1 reference

21 December 2017

language of work or name

English

0 references

publication date

13 March 2012

1 reference

21 December 2017

published in

Vaccine

1 reference

21 December 2017

volume

30

1 reference

21 December 2017

issue

21

1 reference

21 December 2017

page(s)

3147-3150

1 reference

21 December 2017

Nonhospital health care-associated hepatitis B and C virus transmission: United States, 1998-2008.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.02.078

A prospective, randomized, comparative US trial of a combination hepatitis A and B vaccine (Twinrix) with corresponding monovalent vaccines (Havrix and Engerix-B) in adults

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.02.078

Immunogenicity of Twinrix in older adults: a critical analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.02.078

Hepatitis A/B vaccination of adults over 40 years old: comparison of three vaccine regimens and effect of influencing factors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.02.078

Hepatitis-B Vaccination in the Elderly

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.02.078

Immunogenicity of combined hepatitis A and B vaccine in elderly persons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.02.078

Immunogenicity of hepatitis B Vaccines. Implications for persons at occupational risk of hepatitis B virus infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.02.078

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.02.078

A breakthrough case of hepatitis A disease following a full vaccination schedule of three doses of a combined hepatitis A and B vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.02.078

Antibody-response to three recombinant hepatitis B vaccines: comparative evaluation of multicenter travel-clinic based experience

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.02.078

Hepatitis B vaccine responsiveness in Connecticut public safety personnel

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.02.078

Prevention of hepatitis B in nonresponders to initial hepatitis B virus vaccination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.02.078

Immunization against hepatitis B--what can we expect? Results of a survey of antibody response to immunization in persons 'at risk' of occupational exposure to hepatitis B

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.02.078

Evaluation of hepatitis B vaccine immunogenicity among older adults during an outbreak response in assisted living facilities

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.02.078

Excellent response rate to a double dose of the combined hepatitis A and B vaccine in previous nonresponders to hepatitis B vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.02.078

10.1016/J.VACCINE.2012.02.078

7 January 2021

Identifiers

DOI

1 reference

21 December 2017

1 reference

21 December 2017